Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × carotuximab × Clear all

NCT02560779 2020-07-17

Trial of TRC105 and Sorafenib in Patients With HCC

Phase 1/2 Completed

27 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT01306058 2019-01-23

Sorafenib and TRC105 in Hepatocellular Cancer

Phase 1/2 Completed

27 enrolled 32 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms, Liver Neoplasms, Experimental, Adenoma, Liver Cell